CARSGEN-B(02171) has repurchased a total of 7.627 million shares, Yijie Consistent Action Group has increased its holdings by 335,000 shares.

CARSGEN-B (02171) announcement, from October 21, 2025 to December 17, 2025, the company has repurchased a total of 7.627 million shares based on the 2025 share buyback authorization. With approval from the company's board of directors, the deadline of the updated share buyback program has been further extended until the end of the next annual general meeting of shareholders. The board of directors believes that the company's current stock price is lower than its true value and does not fully reflect its business prospects. The board of directors sees the share repurchase plan as a sign of confidence in the company's long-term growth and market performance from the directors and senior management. The board also believes that the share buyback plan is in the overall best interest of the company and its shareholders. The board of directors has recently been informed that Yijie Biotechnology Holdings Limited and its concerted parties (referred to as the "Yijie Concerted Action Group") have collectively purchased 335,000 shares from November 6, 2025 to December 17, 2025. After the shareholding increase, the Yijie Concerted Action Group holds 218,283,730 shares, representing approximately 38.2% of the total number of issued shares (excluding treasury shares) as of the date of this announcement. The board of directors believes that increasing their shareholding shows the confidence of the major shareholders in the company's prospects and growth potential, as well as their recognition of the long-term investment value of the company.